Literature DB >> 18261594

Liver transplantation for biliary atresia.

H Karakayali1, S Sevmis, U Ozçelik, F Ozcay, G Moray, A Torgay, G Arslan, M Haberal.   

Abstract

Biliary atresia is the most common indication for liver transplantation (OLT) in children. We present our experience with OLT as a treatment for end-stage liver disease in children with biliary atresia. We performed a retrospective review of 20 biliary atresia patients (11 male, 9 female patients; mean age, 21.4 months; range, 6 to 84 months) who had undergone OLT. Mean preoperative weight and height were 10.1 +/- 5.8 kg and 72.5 cm, respectively. Thirteen recipients were younger than 1 year of age, and 15 weighed less than 10 kg at the time of OLT. Fourteen recipients had undergone a Kasai operation prior to the OLT. The mean serum total bilirubin level was 22.56 mg/dL before OLT. Eighteen left lateral segment grafts and two whole grafts were transplanted. The mean recipient operative time was 9.25 hours. The mean recipient intraoperative blood loss was 1.81 U. Two hepatic arterial thromboses and one biliary leak occurred soon after surgery. Portal vein stenoses developed in two recipients at 10 and 12 months after OLT; both were treated with balloon dilatation. Two biliary stenoses, which occurred at 10 months and 3.5 years after surgery, were treated with balloon dilatation. Two recipients died at 2 and 12 days after OLT because of respiratory distress syndrome and sepsis, respectively. The remaining 18 (90%) recipients are alive with good graft function. The overall rejection rate was 31.25%. OLT is an effective treatment for children with biliary atresia and a failed Kasai procedure. Living related liver grafts represented an excellent organ supply for these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18261594     DOI: 10.1016/j.transproceed.2007.11.015

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Living Related Liver Transplantation for Biliary Atresia in the Last 5 years: Experience from the First Liver Transplant Program in India.

Authors:  Smita Malhotra; Anupam Sibal; Vidyut Bhatia; Akshay Kapoor; Sarath Gopalan; Swati Seth; Nameet Jerath; Manav Wadhawan; Subash Gupta
Journal:  Indian J Pediatr       Date:  2015-02-25       Impact factor: 1.967

2.  Interactions between Th1 cells and Tregs affect regulation of hepatic fibrosis in biliary atresia through the IFN-γ/STAT1 pathway.

Authors:  Jie Wen; Ying Zhou; Jun Wang; Jie Chen; Wenbo Yan; Jin Wu; Junkai Yan; Kejun Zhou; Yongtao Xiao; Yang Wang; Qiang Xia; Wei Cai
Journal:  Cell Death Differ       Date:  2017-03-17       Impact factor: 15.828

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.